UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease

Journal of neurology, neurosurgery and psychiatry, 2010-06, Vol.81 (6), p.646-649

2010

Volltextzugriff (PDF)

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers

Scientific reports, 2017-06, Vol.7 (1), p.4476-14, Article 4476

2017

Volltextzugriff (PDF)

Clinical features of hereditary spastic paraplegia due to spastin mutation

Neurology, 2006-07, Vol.67 (1), p.45-51

2006

Volltextzugriff (PDF)

Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation

Neuropathology and applied neurobiology, 2013-08, Vol.39 (5), p.562-571

2013

Volltextzugriff (PDF)

Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis

European journal of neurology, 2016-06, Vol.23 (6), p.1071-1078

2016

Volltextzugriff (PDF)

Hereditary spastic paraparesis: a review of new developments

Journal of Neurology, Neurosurgery and Psychiatry, 2000-08, Vol.69 (2), p.150-160

2000

Volltextzugriff (PDF)

Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis

Journal of medical genetics, 2000-10, Vol.37 (10), p.759-765

2000

Volltextzugriff (PDF)

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2023-02, Vol.24 (1-2), p.82-90

2023

Volltextzugriff (PDF)

Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions

Neuropathology and applied neurobiology, 2015-02, Vol.41 (2), p.201-226

2015

Volltextzugriff (PDF)

HSP60 is a rare cause of hereditary spastic paraparesis, but may act as a genetic modifier

Neurology, 2008-05, Vol.70 (19), p.1717-1718

2008

Volltextzugriff (PDF)

Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England

Neurology, 2001-02, Vol.56 (4), p.467-471

2001

Volltextzugriff (PDF)

Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers

Cell death discovery, 2015-09, Vol.1 (1), p.15019-15019, Article 15019

2015

Volltextzugriff (PDF)

Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale

Journal of the neurological sciences, 2021-02, Vol.421, p.117285-117285, Article 117285

2021

Volltextzugriff (PDF)

Post-translational control of the MEF2A transcriptional regulatory protein

Nucleic acids research, 1999-07, Vol.27 (13), p.2646-2654

1999

Volltextzugriff (PDF)

Neuro-ophthalmological Complications of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Neuro-ophthalmology (Amsterdam : Aeolus Press. 1980), 2013-08, Vol.37 (4), p.146-156

2013

Volltextzugriff (PDF)

Macroeconomic Fluctuations in Developing Countries: Some Stylized Facts

The World Bank economic review, 2000-05, Vol.14 (2), p.251-285

2000

Volltextzugriff (PDF)

A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells

Cell death & disease, 2015-10, Vol.6 (10), p.e1944-e1944

2015

Volltextzugriff (PDF)

Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1

Nucleic acids research, 1998-10, Vol.26 (20), p.4771-4777

1998

Volltextzugriff (PDF)

Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle

Journal of molecular and cellular cardiology, 2013-01, Vol.54, p.35-44

2013

Volltextzugriff (PDF)

Development and validation of Spasticity Index—Amyotrophic Lateral Sclerosis

Acta neurologica Scandinavica, 2018-07, Vol.138 (1), p.47-54

2018

Volltextzugriff (PDF)

Heart disease: recruitment of MEF2 activity by β−blockers wards off cardiomyocyte death

Cell death & disease, 2015-10, Vol.6 (10), p.e1916-e1916

2015

Volltextzugriff (PDF)

Investigation of mitochondrial function in hereditary spastic paraparesis

Neuroreport, 2003-03, Vol.14 (3), p.485-488

2003

Volltextzugriff (PDF)

hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors

Molecular and Cellular Biology, 1993-04, Vol.13 (4), p.2564-2577

1993

Volltextzugriff (PDF)

Direct Interaction between Myocyte Enhancer Factor 2 (MEF2) and Protein Phosphatase 1α Represses MEF2-Dependent Gene Expression

Molecular and Cellular Biology, 2009-06, Vol.29 (12), p.3355-3366

2009

Volltextzugriff (PDF)

Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma

Cell death & disease, 2014-02, Vol.5 (2), p.e1094-e1094

2014

Volltextzugriff (PDF)

1 – 25 von 3.103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.808)
Mit Volltextzugriff
(2.485)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.979)
Life Sciences & Biomedicine
(1.592)
Humans
(1.302)
Female
(736)
Male
(727)
Biological And Medical Sciences
(576)
Middle Aged
(485)
Adult
(455)
Medical Sciences
(427)
Aged
(383)
Animals
(326)
Neurosciences & Neurology
(267)
Physical Sciences
(259)
Clinical Neurology
(225)
Oncology
(182)
Fundamental And Applied Biological Sciences. Psychology
(177)
Adolescent
(172)
Physics
(165)
Surgery
(161)
Technology
(159)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers

Clinical features of hereditary spastic paraplegia due to spastin mutation

Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation

Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis

Hereditary spastic paraparesis: a review of new developments

Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months

Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions

HSP60 is a rare cause of hereditary spastic paraparesis, but may act as a genetic modifier

Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England

Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers

Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale

Post-translational control of the MEF2A transcriptional regulatory protein

Neuro-ophthalmological Complications of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Macroeconomic Fluctuations in Developing Countries: Some Stylized Facts

A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells

Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1

Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle

Development and validation of Spasticity Index—Amyotrophic Lateral Sclerosis

Heart disease: recruitment of MEF2 activity by β−blockers wards off cardiomyocyte death

Investigation of mitochondrial function in hereditary spastic paraparesis

hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors

Direct Interaction between Myocyte Enhancer Factor 2 (MEF2) and Protein Phosphatase 1α Represses MEF2-Dependent Gene Expression

Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma

Suchergebnisse filtern